Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

109.44
-0.1600-0.15%
Post-market: 109.440.00000.00%19:30 EDT
Volume:128.97K
Turnover:14.12M
Market Cap:1.01B
PE:88.68
High:110.48
Open:110.00
Low:109.17
Close:109.60
52wk High:118.00
52wk Low:85.91
Shares:9.19M
Float Shares:9.19M
Volume Ratio:0.66
T/O Rate:1.40%
Dividend:2.17
Dividend Rate:1.98%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):140.94

Loading ...

Merck Files Form 3 for EVP, CIDO Gaurav Gupta

Reuters
·
Sep 02

World's Largest Companies by Market Cap (August 2026): Nvidia Retains Top Spot, SpaceX Rebounds 32%, Semiconductor Sector Diverges

TradingKey
·
Sep 02

H.C. Wainwright says Novartis success in RMS trials does not impact TG’s Briumvi

TIPRANKS
·
Sep 01

Rpt: Who: Ervebo Should Only be Used for Bundibugyo Virus (Bvdv) Within the Context of a Research Protocol at This Time

THOMSON REUTERS
·
Sep 01

Novartis MS Trials Open Door to Multibillion-Dollar Sales Opportunity

Dow Jones
·
Sep 01

Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials

TIPRANKS
·
Sep 01

Novartis AG Stock (NVS) Moved Up by 6.54% on Sep 1: Drivers Behind the Movement

TradingKey
·
Sep 01

Novartis's Multiple Sclerosis Trial Results Match Best Hopes

Dow Jones
·
Sep 01

US Stock Alert: Novartis Gains 5% On Positive Late-Stage Trial Results For MS Oral Therapy

Stock News
·
Sep 01

Novartis up Nearly 6%, on Pace for Largest Percent Increase Since March 2023

Dow Jones
·
Sep 01

Sector Update: Healthcare Stocks Mixed Premarket Tuesday

MT Newswires Live
·
Sep 01

【US Pre-Market】US Futures and Chip Stocks Fall as Global Bond Sell-Off Deepens; Gold Drops Below $4,400, Brent Crude Tops $92

TradingKey
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Why Novartis Stock is Heading for Its Best Day Since 2023 After 3 Patient Deaths

Dow Jones
·
Sep 01

NetraMark Appoints Abivax Regulatory Chief Keith Fournier to Board

Reuters
·
Sep 01

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 01

Novartis Shares Climb After Pill Hits Goals in Multiple Sclerosis Trials

Dow Jones
·
Sep 01

Novartis announces results from Phase III Remodel-1/-2 trials of remibrutinib

TIPRANKS
·
Sep 01

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

TIPRANKS
·
Sep 01

Novo Nordisk Launches Wegovy Weight-Loss Pill in Germany

Reuters
·
Sep 01